健康中国

Search documents
响应健康月,南海油脂公益“第一弹”精准落地!多元帮扶构筑学子健康防线
Zhong Guo Shi Pin Wang· 2025-09-23 07:59
Group 1 - The core theme of the public welfare action is "Protecting the Health of Impoverished Students," which marks the launch of a series of public welfare activities by Nanhai Oil and Fat Industry (Chiwan) Co., Ltd. in response to the national "Health Month" initiative [1] - The event is a collaboration between Nanhai Oil and Fat, Dongguan Mali, and a dental expert team from Shenzhen Nanshan Chronic Disease Hospital, focusing on oral health protection, material donations, and financial assistance to support the healthy growth of rural students [3] - This charitable initiative has been ongoing for 11 years, embodying the "Healthy China" concept through practical actions by the company [3] Group 2 - On September 8, dental experts provided engaging oral health lessons to sixth-grade students at Dapo Yihai Primary School, emphasizing the importance of proper brushing techniques [5] - The volunteer team visited multiple impoverished students' families to understand their learning and living conditions, providing essential supplies and scholarships for targeted support [5] - The following day, the team continued their efforts at Jingnao Yihai Primary School in Ganzhou, where parents expressed appreciation for the ongoing support beyond just financial aid [7] Group 3 - As a leading enterprise in the domestic grain and oil industry, Nanhai Oil and Fat integrates the concept of health into its business development and social responsibility practices, promoting public health awareness through a "product + service + public welfare" model [8] - Upcoming health public welfare activities include a nutritional health academic exchange on September 19 and the launch of the 2025 Jinlongyu Fengyitang charity walk at the end of September, advocating for a healthy lifestyle [8] - The "Jinlongyu Fengyitang" brand, launched in April, focuses on functional rice, flour, and oil products, incorporating health management into daily meals, with products like glycerol diester oil (DAG) and plant sterol series [8] - The company aims to build a health ecosystem covering rural children, urban families, and educated groups through diverse public welfare actions, aligning with national health policies and supported by the Jinlongyu Fengyitang health product system [8]
开放投保!2026年度“江苏医惠保1号”正式发布
Xin Hua Ri Bao· 2025-09-23 07:36
Core Viewpoint - The launch of the "Jiangsu Medical Insurance 1" product for 2026 aims to enhance healthcare coverage for residents in Jiangsu Province, providing affordable insurance options with significant benefits and broad coverage [1][5]. Group 1: Product Features - The insurance product offers two premium options: a basic version at 158 yuan per year and an upgraded version at 258 yuan per year, with a maximum coverage of 4 million yuan [1]. - The product covers not only expenses within the basic medical insurance but also includes out-of-pocket costs for high-value medical consumables, rare disease medications, and advanced treatments like proton therapy and CAR-T therapy [2][3]. - The product has achieved a cumulative payout of over 2.7 billion yuan, benefiting nearly 270,000 families, with the highest single payout reaching 804,700 yuan [1]. Group 2: Accessibility and Inclusivity - The insurance has minimal restrictions for enrollment, allowing individuals of any age, health status, or occupation to apply, and it supports family members of insured individuals to purchase coverage [3][6]. - Jiangsu employees can use their individual medical insurance accounts to cover premiums for themselves and their immediate family members, enhancing family health protection [3][6]. Group 3: Claims and Services - The claims process is designed to be efficient, with an average response time of 1.93 days for claims, ensuring quick and reliable service for policyholders [3][4]. - The product includes additional health services, expanding from 34 to 27 continuous health service offerings, emphasizing a supportive role in health management beyond just claims [4]. Group 4: Strategic Importance - The "Jiangsu Medical Insurance 1" product is a key initiative in implementing the "Healthy China" strategy, aiming to improve the multi-tiered medical insurance system and enhance the public's ability to cope with major health risks [5].
研判2025!中国再生运动医学医疗器械行业市场规模、投融资情况及未来趋势分析:在“全民健身”热潮及人口老龄化加剧的背景下,行业迎来良好发展机遇[图]
Chan Ye Xin Xi Wang· 2025-09-23 01:19
内容概要:运动再生医学医疗器械是指再生或恢复关节软组织(如韧带、肌腱及软骨)的疗法及生物材 料。该等医疗器械区别于传统的使用机械固定的医疗器械,利用了生物学及组织工程技术,旨在实现从 修补到再生的转变,从而将重心由修补技术转移到再生疗法。当前,全民健身成为一种风潮,根据国家 体育总局数据,截至2024年,经常参加体育锻炼人数比例超过38.5%,较2014年提升4.6个百分点。面对 越来越多的运动损伤诊疗和康复需求,运动再生医学医疗器械迎来良好发展机遇。同时骨关节炎等退行 性疾病及慢性肌腱损伤患病率的上升,也推动运动再生医学医疗器械市场的发展。人口老龄化及肥胖率 上升等因素加剧了关节、软骨和结缔组织的负荷,导致这类疾病愈发常见。运动再生医学医疗器械有望 恢复组织功能、延缓病情进展并改善长期疗效。运动再生医学医疗器械为运动医学重要组成部分,行业 发展迅速,但目前市场规模仍较小。2024年全球运动再生医学医疗器械市场规模为9亿美元,2018-2024 年期间实现年复合增长率33.3%。中国运动再生医学医疗器械市场规模则由2020年的1亿元增长至2024 年的8亿元,2024年占运动医学总规模的14.8%。目前国内相 ...
国评企业家健康管理基地正式揭牌,美年健康与国评创新医疗开启战略合作
Sou Hu Cai Jing· 2025-09-22 12:09
Core Insights - The strategic partnership between Meinian Health Group and Beijing Guoping Innovation Medical Technology Co., Ltd. aims to create a health management platform that integrates technology, medical resources, and corporate service needs, focusing on health check-ups, chronic disease rehabilitation, and health management services for enterprises and individuals [1][5][12] Group 1: Partnership Details - The collaboration is marked by the establishment of the "Guoping Entrepreneur Health Management Base," which will focus on personalized health screening, comprehensive health management, and high-end medical resource integration [5][11] - The partnership is a response to the uneven distribution of medical resources in China and aims to address the urgent health management needs of entrepreneurs [7][13] Group 2: Key Figures and Leadership - Key figures present at the signing ceremony included Meinian Health Group's Vice Chairman Guo Meiling, President Xu Tao, and Guoping's Chairman Liu Xiaoming, highlighting the importance of leadership in this initiative [3][11] - The first batch of membership cards was issued to entrepreneurs, marking the commencement of services at the health management base [12] Group 3: Technological Integration - Meinian Health is leveraging big data and AI technologies to build the largest personal health data center in China, developing smart systems to enhance health management services [5][12] - The collaboration will utilize AI-driven health management tools to create a seamless service loop from health check-ups to interventions and follow-ups [5][13] Group 4: Health Challenges and Solutions - The initiative addresses significant health challenges faced by entrepreneurs, including the need for urgent medical access and personalized health management [13] - The health management base will provide a range of services, including health assessments, emergency hospitalization coordination, and 24/7 health management support [13]
“达能营养周”全面升级 聚焦健康老龄化与全民营养提升
Yang Zi Wan Bao Wang· 2025-09-22 11:40
Group 1 - The aging population in China, with over 300 million people aged 60 and above, is driving the importance of nutritional intervention as a key component of the "Healthy China" strategy [1] - Danone China has upgraded its "Danone Nutrition Week" during the 17th National Nutrition Science Conference, focusing on scientific communication and public engagement to promote nutritional awareness [1][3] - Danone's President for China, North Asia, and Oceania, emphasized the company's mission to provide health through food and its commitment to integrating scientific innovation with local needs [1][5] Group 2 - The "Nutrition and Healthy Longevity" sub-forum at the National Nutrition Science Conference featured over 200 experts discussing the importance of early and systematic nutritional intervention for achieving public health and longevity [3] - Chen Junshi, an advisor at the National Center for Food Safety Risk Assessment, highlighted the growing significance of nutrition in public health and acknowledged Danone's contributions to the development of nutrition science in China [5] - Danone, in collaboration with the Chinese Nutrition Society, launched the "2025 Danone Dietary Nutrition Research Fund," focusing on nutrition and aging, with over 300 funded research projects totaling more than 53 million yuan [5][7] Group 3 - Yang Yuexin, President of the Chinese Nutrition Society, praised Danone's long-term support for nutrition science in China and expressed hope that the upgraded "Danone Nutrition Week" would enhance research and contribute to building a healthy China [7] - Danone has previously conducted annual nutrition weeks for employees and is now expanding this initiative to the public, aiming to disseminate quality nutritional concepts widely [7] - The comprehensive upgrade of "Danone Nutrition Week" signifies the company's commitment to its promise of "In China, For China," focusing on scientific innovation and social value integration for a healthier future [7]
超拼网在京承办2025中医药文化传承发展论坛暨中医药溯源直播间启动仪式
Sou Hu Wang· 2025-09-22 11:26
Group 1 - The forum titled "Inheritance of Traditional Chinese Medicine Culture and Development" was held, focusing on promoting transparency and quality assurance in the TCM industry [1][10] - The launch of the "TCM Traceability Live Room" aims to enhance public trust in TCM products and facilitate a direct connection between consumers and the source of TCM products [5][12] - The event featured speeches from industry leaders and experts, emphasizing the importance of digital technology in modernizing TCM practices and ensuring product quality [3][14] Group 2 - The company, Chaopin Network, is committed to building an intelligent health service system that connects the source of TCM products directly to households, focusing on the silver economy and family health services [5][14] - The forum served as a platform for discussing the standardization and transparency of TCM, with a roundtable dialogue on the practices and prospects of traceability for authentic medicinal materials [10][12] - The event significantly enhanced Chaopin Network's credibility and influence in the TCM sector, showcasing its dedication to empowering traditional medicine through e-commerce [14]
湖南夫妇卖背背佳:年入29.83亿,全国第一,港股上市
Sou Hu Cai Jing· 2025-09-22 10:57
Core Viewpoint - The company Kefu Medical, known for its home health products, is preparing for an IPO on the Hong Kong Stock Exchange, aiming for a dual listing in both A-share and H-share markets [2] Company Overview - Kefu Medical, headquartered in Hunan, specializes in home health products such as blood pressure monitors, blood glucose meters, hearing aids, wheelchairs, nebulizers, and COVID-19 testing kits [3][4] - As of September 22, 2023, Kefu Medical has a market capitalization of 8.241 billion RMB [5] Business Development - Founded by Zhang Min in 2007, Kefu Medical started as a small medical device retail store and has since evolved into a significant player in the home medical device market [6][8] - The company launched its first online flagship store on Tmall in 2014, expanding its sales channels and reaching consumers in remote areas [10] Product Line and Revenue - Kefu Medical offers over 200 products across five core treatment areas: rehabilitation aids, medical care, health monitoring, respiratory support, and traditional Chinese medicine therapy [11] - In 2024, the revenue from rehabilitation aids is projected to be 1.039 billion RMB, accounting for 34.8% of total revenue, with the "Beibeijia" posture corrector holding a nearly 30% market share in its category [12] Sales Channels - Online sales dominate Kefu Medical's revenue structure, contributing 1.981 billion RMB (66.4% of total revenue) in 2024, with significant performance on platforms like Tmall, JD, Douyin, and Xiaohongshu [14] - The company operates 738 self-owned stores, primarily "Jianer Hearing" service centers, covering over 135 cities [14] Market Presence - Kefu Medical ranks second in the Chinese home medical device market by sales revenue and first in the rehabilitation aids segment [16] - The "Beibeijia" brand leads in sales of posture correctors, while the "Jianer Hearing" brand ranks among the top three in the hearing aid industry [17][18] Financial Performance - Kefu Medical's revenue for 2022, 2023, and 2024 was 2.977 billion RMB, 2.854 billion RMB, and 2.983 billion RMB, respectively, with a gross profit margin improvement from 37.8% in 2022 to 50.6% in 2024 [19] Industry Trends - The aging population in China, with over 310 million people aged 60 and above by 2024, drives demand for home medical devices [20] - The increasing public health awareness and the growing chronic disease patient population further enhance the need for home health management solutions [22] Future Opportunities - The home medical device industry is undergoing significant transformation, with opportunities arising from smart technology integration, diversified consumer groups, multi-functional products, and the rise of domestic brands [23][24][28]
科技赋能,健康领航——国评企业家健康管理基地正式揭牌,美年健康与国评创新医疗开启战略合作
Sou Hu Cai Jing· 2025-09-22 04:06
Core Viewpoint - The strategic cooperation between Meinian Health Group and Beijing Guoping Innovation Medical Technology Co., Ltd. aims to establish a health management platform that integrates technology, medical resources, and corporate service needs, focusing on health check-ups, chronic disease rehabilitation, and health management services for individuals and enterprises [1][5]. Group 1: Strategic Cooperation Details - The partnership will leverage Meinian Health's AI technology and expert resources from top-tier hospitals to create personalized health check-up plans [5]. - The collaboration will establish a comprehensive health management loop, utilizing the AI health assistant "Health Xiaomei" to create digital health records for entrepreneurs, facilitating integrated services from health check-ups to follow-ups [5][13]. - The initiative is aligned with the "Healthy China" strategy, aiming to provide robust health management solutions for entrepreneurs, addressing their unique health challenges [5][8]. Group 2: Key Participants and Contributions - Key figures at the signing ceremony included Meinian Health's Vice Chairperson Guo Meiling, President Xu Tao, and Guoping Innovation's Chairman Liu Xiaoming, highlighting the significance of the event [4][10]. - Liu Xiaoming emphasized the need for this cooperation due to the uneven distribution of medical resources in China and the urgent health management needs of entrepreneurs [8][13]. - The partnership is expected to enhance the credibility and professionalism of the health management platform, addressing the health pain points faced by entrepreneurs [8][12]. Group 3: Future Directions and Innovations - Meinian Health plans to continue innovating in the health sector by integrating advanced medical resources and technologies, focusing on specialized health products for various health needs [12][13]. - The health management base will provide a range of services, including emergency medical support, health assessments, and 24/7 dedicated health management teams for entrepreneurs [13]. - This collaboration represents a significant step towards creating a new benchmark in high-end health management services, contributing to the overall health and economic vitality of the entrepreneurial community in China [13].
推动构建消费维权共治格局 2025品质健康与消费者权益保护会议在京举办
Zhong Guo Jing Ji Wang· 2025-09-22 03:48
9月19日,由中国消费者协会指导、中国消费者杂志社主办的"诚信品质创新"——2025品质健康与消费者权益保护会议在京举办。中国消费者杂志社发布 的健康消费调查、体察报告(以下简称"报告")指出,随着居民健康意识提升,消费需求升级,健康消费领域不断拓展,但其服务短板日益凸显。 报告显示,涉老私域直播"暗域"涉诈问题频发,近半数受访者遭遇私域直播虚假宣传,42.35%的受访者遭遇"以次充好",维权存证率低至14.32%;睡眠消 费市场潜力大,超七成受访者睡眠时长不达标,近六成使用助眠产品后出现不良反应;养疗消费需求旺盛,97.87%的受访者存在亚健康问题,74.68%的 受访者接受养疗服务,但超三成受访者遭遇过虚假宣传;情绪消费热潮兴起,近七成受访者通过消费缓解压力,但40.12%的受访者遭遇服务质量问题, 三成受访者遇到承诺不符与诱导消费……面对当前相关行业乱象,报告认为,需构建"平台自律、监管智能、消费者教育"多元共治体系,压实各方责任, 筑牢健康消费安全防线。 本次大会聚焦消费者关注的健康话题,立足不同视角,从监管政策到诚信自律、合规经营,从消费生态到产业发展,从营商环境到满意消费,既直面"健 康消费信任痛 ...
2025社保与养老金融论坛聚焦 “高质量低成本” 健康保障之路
Xin Hua Cai Jing· 2025-09-21 14:54
Core Viewpoint - The "2025 Social Security and Pension Finance International Summit Forum" held in Shanghai emphasizes the importance of advancing the Healthy China strategy and achieving high-quality development in social security as critical issues for national welfare and social stability [1][2]. Group 1: Current Challenges in Social Security - China's aging population is accelerating, leading to a growing demand for quality health services and a reinforcement of traditional family caregiving roles, highlighting a mismatch between the increasing health security needs of the elderly and the existing social security system's adaptability [2]. - The current pension system faces three major bottlenecks: significant disparities in basic pension benefits across regions and urban-rural areas, a narrow coverage of enterprise annuities, and low participation in third-pillar pension financial products [2][5]. Group 2: Proposed Solutions and Innovations - Financial technology is suggested as a means to reconstruct the pension ecosystem, utilizing AI and big data for dynamic analysis of user needs and personalized asset allocation [3]. - A unified national health information platform is recommended to manage health throughout the life cycle, supported by wearable devices and cloud technology [3]. - The need for a dual approach to address the challenges of the aging population is emphasized, focusing on both supply-side technological innovations and demand-side consumption upgrades [6]. Group 3: International Perspectives and Economic Implications - The silver economy is viewed as a potential driver for global growth, with China's approach to aging governance providing valuable insights for other countries [2]. - The aging population impacts the economy through reduced labor supply, lower savings and investment rates, and diminished innovation capacity [6]. Group 4: Research and Policy Developments - The establishment of a comprehensive evaluation index system for the "Healthy China" initiative aims to enhance health levels and promote a healthy lifestyle [6]. - The release of the "Shanghai Social Security Reform and Development Report (2025)" outlines innovative practices and policy recommendations in social security and pension finance [6].